Vaccines Program
One challenge associated with many vaccines today is the requirement for the vaccine to be injected. In collaboration with researchers at the University of New South Wales, and the University of Queensland, Prima Biomed is researching ways to make vaccines that are currently injected effective when administered orally. The initial approach being taken is to make nanoparticles, small protein beads that then are coated with vaccine, and a protective layer to prevent damage to the vaccine by stomach acid. The nanoparticles have a high surface area containing vaccine to present to the small intestine. The first target for the nanoparticle vaccine is Human Papillloma Virus (HPV). The program is in early stage development.
09/04/2010
|
|